RMCM
AVEO

Reynders McVeigh Capital Management’s AVEO Pharmaceuticals, Inc. AVEO Stock Holding History

Reynders McVeigh Capital Management’s Portfolio AVEO Stock Details AVEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-1,260
Closed -$15K – 215
2015
Q3 		$15K Hold
1,260
– – ﹤0.01% 200
2015
Q2 		$22K Hold
1,260
– – ﹤0.01% 203
2015
Q1 		$18K Buy
+1,260
New +$13.8K ﹤0.01% 173

Other funds holding AVEO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
GCM
Gruss Capital Management New York $715M AUM 9.91% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
DVC
Deer VI & Co Larchmont, New York $2.23M AUM 9.32% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Reynders McVeigh Capital Management's AVEO Position: Q4 2015 in Review

Reynders McVeigh Capital Management sold out of AVEO Pharmaceuticals, Inc. (AVEO) in Q4 2015, closing a stake of 1,260 shares — an estimated $15K sold.

Reynders McVeigh Capital Management first reported a position in AVEO in Q1 2015 and held it in 3 quarters. The position peaked at $22K in Q2 2015. 44 funds tracked by Wall St. Rank hold AVEO as of Q4 2015.

  • Reynders McVeigh Capital Management reported no remaining AVEO Pharmaceuticals, Inc. position as of Q4 2015 after selling out during the quarter.
  • Reynders McVeigh Capital Management sold 1,260 AVEO Pharmaceuticals, Inc. shares in Q4 2015, an estimated $15K.
  • Reynders McVeigh Capital Management first reported a position in AVEO Pharmaceuticals, Inc. in Q1 2015 and held it in 3 quarters.
  • Reynders McVeigh Capital Management's AVEO Pharmaceuticals, Inc. position peaked at $22K in Q2 2015.
  • 44 funds tracked by Wall St. Rank held AVEO Pharmaceuticals, Inc. as of Q4 2015.

Based on Reynders McVeigh Capital Management's 13F filing for Q4 2015, filed 16 Feb 2016.